Alyeska Investment Group — TEVA Trade History
Quarter-by-quarter changes in the TEVA PHARMACEUTICAL INDS LTD position · CUSIP 881624209
Currently held · 3.5 YearsFirst seen: 2023 Q1
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Add | 6,257,579 | 738,549 | +13.4% | $212.0M | 0.55% |
| 2026 Q1 | 2026-05-15 | Add | 5,519,030 | 1,983,068 | +56.1% | $166.2M | 0.47% |
| 2025 Q4 | 2026-02-13 | Reduce | 3,535,962 | -2,440,073 | -40.8% | $110.4M | 0.31% |
| 2025 Q3 | 2025-11-17 | Add | 5,976,035 | 3,545,577 | +145.9% | $120.7M | 0.36% |
| 2025 Q2 | 2025-08-14 | Reduce | 2,430,458 | -795,155 | -24.7% | $40.7M | 0.14% |
| 2025 Q1 | 2025-05-15 | Reduce | 3,225,613 | -415,779 | -11.4% | $49.6M | 0.20% |
| 2024 Q4 | 2025-02-14 | Add | 3,641,392 | 16,392 | +0.5% | $80.3M | 0.30% |
| 2024 Q3 | 2024-11-14 | Reduce | 3,625,000 | -203,871 | -5.3% | $65.3M | 0.33% |
| 2024 Q2 | 2024-08-14 | Reduce | 3,828,871 | -2,516,937 | -39.7% | $62.2M | 0.36% |
| 2024 Q1 | 2024-05-15 | Add | 6,345,808 | 886,499 | +16.2% | $89.5M | 0.55% |
| 2023 Q4 | 2024-02-14 | Reduce | 5,459,309 | -1,003,267 | -15.5% | $57.0M | 0.38% |
| 2023 Q3 | 2023-11-14 | Add | 6,462,576 | 4,962,576 | +330.8% | $65.9M | 0.45% |
| 2023 Q2 | 2023-08-14 | Add | 1,500,000 | 700,000 | +87.5% | $11.3M | 0.08% |
| 2023 Q1 | 2023-05-15 | New | 800,000 | 800,000 | — | $7.1M | 0.06% |
| 2022 Q4 | 2023-02-14 | — | — | — | — | — | — |
| 2022 Q3 | 2022-11-14 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-15 | — | — | — | — | — | — |
| 2021 Q4 | 2022-05-19 | — | — | — | — | — | — |
| 2021 Q3 | 2022-05-19 | — | — | — | — | — | — |
| 2021 Q2 | 2022-05-19 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-17 | — | — | — | — | — | — |
| 2020 Q3 | 2021-08-24 | — | — | — | — | — | — |
| 2020 Q4 | 2021-08-24 | — | — | — | — | — | — |
| 2021 Q1 | 2021-08-24 | — | — | — | — | — | — |
| 2020 Q1 | 2021-02-24 | — | — | — | — | — | — |
| 2020 Q2 | 2021-02-24 | — | — | — | — | — | — |
| 2019 Q2 | 2020-08-18 | — | — | — | — | — | — |
| 2019 Q3 | 2020-08-18 | — | — | — | — | — | — |
| 2019 Q4 | 2020-08-18 | — | — | — | — | — | — |
| 2019 Q1 | 2020-05-22 | — | — | — | — | — | — |
| 2018 Q4 | 2020-05-22 | — | — | — | — | — | — |
| 2018 Q2 | 2019-05-21 | — | — | — | — | — | — |
| 2018 Q3 | 2019-05-21 | — | — | — | — | — | — |
| 2017 Q3 | 2019-02-21 | — | — | — | — | — | — |
| 2017 Q4 | 2019-02-21 | — | — | — | — | — | — |
| 2018 Q1 | 2019-02-21 | — | — | — | — | — | — |
| 2016 Q4 | 2018-08-20 | — | — | — | — | — | — |
| 2017 Q1 | 2018-08-20 | — | — | — | — | — | — |
| 2017 Q2 | 2018-08-20 | — | — | — | — | — | — |
| 2015 Q4 | 2017-08-17 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.